Results 151 to 160 of about 11,074 (164)

Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study

Annals of Oncology, 2018
Rafal Dziadziuszko, Åslaug Helland, In-Jae Oh   +2 more
exaly  

Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC

Journal of Thoracic Oncology, 2018
Gregory J Riely, Anna F Farago, Jessica J Lin   +2 more
exaly  

Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study

Annals of Oncology, 2018
Solange Peters, Tony Mok, D R Camidge
exaly  

Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects

Clinical Pharmacology in Drug Development, 2017
Neil Parrott, Peter N Morcos, Elena Guerini   +2 more
exaly  

LC–MS/MS Determination of Alectinib and its Major Human Metabolite M4 in Human Urine: Prevention of Nonspecific Binding

Bioanalysis, 2017
Peter N Morcos, Katja Heinig
exaly  

Adsorption Properties of the New Anti-Cancer Drug Alectinib on CNT(6,6-6) Nanotube: Geometry Optimization, Molecular Structure, Spectroscopic (NMR, UV/Vis, Excited State), FMO, MEP and HOMO–LUMO Investigations

Journal of Cluster Science, 2018
Masoome Sheikhi, Siyamak Shahab, Radwan Alnajjar   +2 more
exaly  

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Lung Cancer, 2020
Yuichi Takiguchi, Hiroshige Yoshioka, Toshiyuki Kozuki   +2 more
exaly  

Effect of alectinib on cardiac electrophysiology: results from intensive electrocardiogram monitoring from the pivotal phase II NP28761 and NP28673 studies

Cancer Chemotherapy and Pharmacology, 2017
Peter N Morcos, Ali Zeaiter, Bogdana Balas   +2 more
exaly  

Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib

Journal of Clinical Pharmacology, 2018
Neil Parrott, Peter N Morcos, Elena Guerini   +2 more
exaly  

A molecular dynamics investigation into the mechanisms of alectinib resistance of three ALK mutants

Journal of Cellular Biochemistry, 2018
Qing-Chuan Zheng
exaly